148
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation

, , , &
Pages 115-125 | Received 08 Jun 2011, Accepted 03 Oct 2011, Published online: 02 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aya Ahmed Sebak, Iman Emam Omar Gomaa, Aliaa Nabil ElMeshad, Mahmoud Hussien Farag, Ulrike Breitinger, Hans-Georg Breitinger & Mahmoud Hashem AbdelKader. (2020) Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part I: In vitro Release and Intracellular Uptake Perspective. International Journal of Nanomedicine 15, pages 8845-8862.
Read now

Articles from other publishers (5)

Maria João Ramalho, Maria Bravo, Joana Angélica Loureiro, Jorge Lima & Maria Carmo Pereira. (2022) Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Life Sciences 296, pages 120435.
Crossref
Mazen M. El-Hammadi & José L. Arias. (2022) Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines. Nanomaterials 12:3, pages 354.
Crossref
Lin Liu, Hui Yang, Yan Lou, Jia-Ying Wu, Jing Miao, Xiao-Yang Lu & Jian-Qing Gao. (2019) Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. International Journal of Pharmaceutics 557, pages 170-177.
Crossref
Ana I Ramos, Pedro D Vaz, Susana S Braga & Artur M S Silva. (2017) Association of aescin with β- and γ-cyclodextrins studied by DFT calculations and spectroscopic methods. Beilstein Journal of Nanotechnology 8, pages 348-357.
Crossref
Néstor Mendoza-Muñoz, Sergio Alcalá-Alcalá & David Quintanar-Guerrero. 2016. Polymer Nanoparticles for Nanomedicines. Polymer Nanoparticles for Nanomedicines 87 121 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.